MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
MTVA Key Statistics
Stock Snapshot
With a market cap of 22.89M, MetaVia(MTVA) trades at $9.40. The stock has a price-to-earnings ratio of -0.65.
On 2025-12-25, MetaVia(MTVA) stock traded between a low of $9.40 and a high of $9.81. Shares are currently priced at $9.40, which is 0.0% above the low and -4.1% below the high.
The MetaVia(MTVA)'s current trading volume is 22.8K, compared to an average daily volume of 48.25K.
During the past year, MetaVia(MTVA) stock moved between $6.05 at its lowest and $30.25 at its peak.
During the past year, MetaVia(MTVA) stock moved between $6.05 at its lowest and $30.25 at its peak.
MTVA News
MetaVia (MTVA) announced that on December 19, 2025, it received formal notice from The Nasdaq Stock Market indicating that the company has regained compliance w...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...